From Our Partners
Friday, June 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DoD Critical Reagents Improved by DARPA Antibody Program

by Global Biodefense Staff
February 22, 2013

MS2 Bacteriophage (DARPA)For the past several years, the Defense Advanced Research Projects Agency (DARPA) has spearheaded an unprecedented effort to improve the affinity and stability of antibodies used by military biosensors in the field. 

Working with industry partners, the DARPA Antibody Technology Program (ATP) set out in 2009 with two primary goals: achieve revolutionary improvements in the stability of antibodies over time, even in extreme conditions; and control affinity in biosensors to enable detection of numerous antigens by a single unit. 

ATP ended in 2012 having achieved both of these goals. Antibody affinity was increased by a factor of 400, opening the door to vastly more sensitive, multiplexed biosensors. Temperature stability was increased to 70 degrees Celsius (158F) for 48 hours, a dramatic improvement from the prior limit of five to ten minutes.  

Perhaps the most impactful of these results is the potential to eliminate the need for cold storage of the immunoassays. The program achievements in temperature stability at the high end translate to an increase in shelf-life at room temperature from one month to approximately three years. ATP achieved these results by altering the amino acid sequences within the antibody molecules, rather than creating an additive stabilizing material.

“By removing temperature stability as a limiting factor, troops will now be able to carry sensors with them without worrying about refrigeration and wondering if the sensor will return an accurate reading,” said Mildred Donlon, DAPRA Program Manager for ATP. “The new stability also means antibodies can be attached to new materials to make potentially more practical sensors to take the place of current beads and strips.”

The ATP technologies are now being transitioned to DoD’s Critical Reagents Program (CRP), part of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), for use in biodetection equipment throughout the military services. 

DARPA partners for the ATP program included: Edgewood Chemical Biological Center, Naval Research Laboratory, University of Texas at Austin, Affomix Corp. (now part of Illumina), AnaptysBio, StableBody Technologies, and AxioMx, Inc. 

Source and additional details: DARPA Press Release.

From Our Partners
Tags: Chemical DetectionDARPAECBCJPEO-CBRND

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC